Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Tax Rate (2024 - 2025)

Updated

Innocan Pharma's Tax Rate was 501.18% in the year ended Dec 31, 2025, up 372.67 percentage points from 128.51% a year earlier.

Analysis

Innocan Pharma (INNPF) Tax Rate (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Tax Rate in earlier years was 128.51% in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 23.26%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 12.61%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 8.85%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.54%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 20.70%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.96%
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 793.94%
Dec 31, 2024 1,700.00%
Sep 30, 2024 59.54%
Jun 30, 2024 33.33%
API Access

Innocan Pharma Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=INNPF&period=max&api_key=YOUR_API_KEY